Evidence map›Paper›PMID 42738881›Full record

ArticleCells2026

Age-Associated YBX1 Phosphorylation Regulates the Keratinocyte Senescence-Associated Secretory Phenotype Through Translational Control.

Valdi Ven Japranata, Michelle Liu, Fabiana Boncimino, Emery Di Cicco, Sara Palumbo, Kristina Todorova, Enkhtuul Gantumur, Stefano Sol, Anna Mandinova

Abstract read
In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Valdi Ven JapranataCutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.ORCID 0000-0001-8215-9418
Michelle LiuCutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.ORCID 0009-0009-2205-1013
Fabiana BonciminoCutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.ORCID 0009-0002-9409-7757
Emery Di CiccoCutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
Sara PalumboCutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.ORCID 0009-0002-8733-5059
Kristina TodorovaCutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.ORCID 0009-0008-4225-6860
Enkhtuul GantumurCutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.ORCID 0000-0002-1549-6374
Stefano SolCutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.ORCID 0000-0003-2576-0156
Anna MandinovaCutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.ORCID 0000-0001-9273-0972

Funding

Stem Cell Integral Membrane Transporter ABCB5 and Dermal RegenerationP01AG071463 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI Markus H. Frank · 2022 to 2026
$13.6M
NIA NIH HHS P01 AG071463NIH HHS 1P01AG071463-02
6 · The paper itself

Abstract

Skin aging is characterized by epidermal atrophy, reduced keratinocyte proliferation, and the accumulation of senescent cells that sustain a chronic, low-grade inflammatory secretome known as the senescence-associated secretory phenotype (SASP). We previously showed that Y-box binding protein 1 (YBX1) limits keratinocyte senescence in human epidermis by acting as a translational repressor of SASP chemokines, including CXCL1 and IL8. How this brake is regulated during skin aging, however, remains undefined. Here we demonstrate that, although total YBX1 protein is reduced in keratinocytes from aged human epidermis, the fraction of phosphorylated YBX1 (pYBX1) is increased relative to young donors, resulting in an elevated pYBX1/total YBX1 ratio that correlates with chronological age. Because pYBX1 is predominantly nuclear, whereas unphosphorylated YBX1 is cytoplasmic, this shift is predicted to deplete the cytoplasmic pool available for translational repression of CXCL1 and IL8. Consistent with this model, treatment of immortalized (Ker-CT) and primary human keratinocytes (HK) with the PI3K inhibitors PI-103 and GDC-0941 suppressed YBX1 phosphorylation without altering total YBX1 abundance, thus retaining YBX1 in the cytoplasm. This allows cytoplasmic YBX1 to re-engage and repress the translation of

Indexed as

AgingCellular SenescenceKeratinocytesProtein BiosynthesisSenescence-Associated Secretory PhenotypeY-Box-Binding Protein 1Chemokine CXCL1HumansInterleukin-8PhosphorylationSkin AgingChemokine CXCL1Interleukin-8Y-Box-Binding Protein 1YBX1 protein, humankeratinocyte senescencephosphorylationpost-transcriptional regulationskin agingYBX1

Identifiers

PMID42738881
PMCPMC13564713

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.